TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1537535

Group type: EXPERIMENTAL
Intervention: Electrohydraulic water-bath lithotripter at 18 +/- 1 kV (Group A, n = 20)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Electrohydraulic water-cushion lithotripter at 19 +/- 2 kV (Group B, n = 25)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Electrohydraulic water-cushion lithotripter at 22 +/- 2 kV (Group C, n = 41)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Comparison of Group A and Group B
Number of subjects: 86
Study: 6505269

Group type: EXPERIMENTAL
Intervention: High doses of alpha 2 Interferon (20 X 10(6) I.U./m2 subcutaneously three times weekly for 3 months)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High doses of alpha 2 Interferon (50 X 10(6) I.U./m2 intravenously daily for 5 consecutive days every 4 weeks)
Number of subjects: 18
Study: 31374019

Group type: EXPERIMENTAL
Intervention: Rational-emotive language education (RELE)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 68
Study: 29945650

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT) with telephone support
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Healthy lifestyle intervention
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (active waiting list)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups (including those without depression)
Number of subjects: 90
Study: 26756623

Group type: EXPERIMENTAL
Intervention: Object-related bilateral symmetrical training with mirror therapy (MT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group observing the paretic upper limb directly
Number of subjects: 16
Study: 25306688

Group type: EXPERIMENTAL
Intervention: Epidural blockade with local anesthetics and small doses of steroids
Number of subjects: 90
Study: 22488227

Group type: EXPERIMENTAL
Intervention: Lumbopelvic joint manipulation (grade V)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Side‐lying lumbar midrange flexion and extension passive range of motion (grade II) for 1 minute
Number of subjects: 48

Group type: COMPARATOR
Intervention: Prone extension on the elbows for 3 minutes
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: All groups pooled
Number of subjects: 48
Study: 20569758

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 2835

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2835
Study: 18052566

Group type: EXPERIMENTAL
Intervention: Agomelatine 25-50 mg/day
Number of subjects: 332

Group type: COMPARATOR
Intervention: Venlafaxine 75-150 mg/day
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Agomelatine
Number of subjects: 332

Group type: COMPARATOR
Intervention: Venlafaxine
Number of subjects: 332
Study: 15657688

Group type: EXPERIMENTAL
Intervention: Spouse dysfunctional problem-solving
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Spouse distress
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Spouse constructive problem-solving
Number of subjects: 171
Study: 12399273

Group type: EXPERIMENTAL
Intervention: 1 mmol arginine/kg lean body mass
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1 mmol arginine/kg lean body mass + 25 g glucose
Number of subjects: 9

Group type: COMPARATOR
Intervention: 25 g glucose alone
Number of subjects: 9

Group type: COMPARATOR
Intervention: Water only
Number of subjects: 9
Study: 10455343

Group type: EXPERIMENTAL
Intervention: CD34+ selected grafts using Isolex 300 device
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: CD34+ selected grafts using Isolex 300i device
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (unmanipulated PBPC)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Overall purging efficacy
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Serological parameters at 12 months post-transplant
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Transient monoclonal or oligoclonal gammopathies
Number of subjects: 26
Study: 8949760

Group type: EXPERIMENTAL
Intervention: Neutron therapy
Number of subjects: 119

Group type: COMPARATOR
Intervention: Photon therapy
Number of subjects: 119
Study: 1924653

Group type: EXPERIMENTAL
Intervention: Type A counseling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cardiac control group
Number of subjects: 0
Study: 6805791

Group type: EXPERIMENTAL
Intervention: Ultraclean-air operating rooms
Number of subjects: 8000

Group type: COMPARATOR
Intervention: Conventional ventilation operating rooms
Number of subjects: 8000

Group type: EXPERIMENTAL
Intervention: Ultraclean-air operating rooms with whole-body exhaust-ventilated suits
Number of subjects: 8000

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 8000

Group type: COMPARATOR
Intervention: No antibiotic prophylaxis
Number of subjects: 8000
Study: 29752776

Group type: EXPERIMENTAL
Intervention: Supraglottic airway (SGA) management in 72.7% of cases (n = 152)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Endotracheal intubation (ETI)
Number of subjects: 220
Study: 28412747

Group type: EXPERIMENTAL
Intervention: Selenomethionine (SEMET)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Methyl selenocysteine (MSC)
Number of subjects: 29
Study: 27355279

Group type: EXPERIMENTAL
Intervention: Lavender aroma
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Positive prime (regardless of aroma type)
Number of subjects: 92
Study: 24444781

Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 12515

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12515

Group type: EXPERIMENTAL
Intervention: Low-dose ASA
Number of subjects: 12515

Group type: EXPERIMENTAL
Intervention: Medium-dose ASA
Number of subjects: 12515

Group type: EXPERIMENTAL
Intervention: High-dose ASA
Number of subjects: 12515
Study: 22531418

Group type: EXPERIMENTAL
Intervention: γ-secretase inhibitor semagacestat (100 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: γ-secretase inhibitor semagacestat (140 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: γ-secretase inhibitor semagacestat (280 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 20805115

Group type: EXPERIMENTAL
Intervention: E5555 (50 mg)
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: E5555 (100 mg)
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: E5555 (200 mg)
Number of subjects: 504

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: E5555 (combined)
Number of subjects: 504
Study: 17683649

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 0
Study: 15177806

Group type: EXPERIMENTAL
Intervention: Task switching between auditory and visual modalities
Number of subjects: 0
Study: 11881864

Group type: EXPERIMENTAL
Intervention: β-adrenergic antagonists (β‐AAs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acute administration of β‐AAs
Number of subjects: 0
Study: 9792124

Group type: EXPERIMENTAL
Intervention: Professional tooth-cleaning and dental health education programme (test)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Standard preventive programme (control) comprising selective fissure sealing and application of topical fluorides
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Both groups (test and control)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Standard preventive programme (control)
Number of subjects: 404
Study: 7715038

Group type: EXPERIMENTAL
Intervention: Active compression-decompression (ACD) CPR
Number of subjects: 860

Group type: COMPARATOR
Intervention: Standard manual CPR
Number of subjects: 860
Study: 1939686

Group type: EXPERIMENTAL
Intervention: Educational course in child maltreatment
Number of subjects: 50
Study: 6102940

Group type: EXPERIMENTAL
Intervention: Alprazolam (0.5‐3.0 mg)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Diazepam (5‐60 mg)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 31142369

Group type: EXPERIMENTAL
Intervention: Standard PEEP (6-8 cm H2O)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Low PEEP (≤2 cm H2O)
Number of subjects: 208
Study: 29061359

Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate pulpotomy
Number of subjects: 54

Group type: COMPARATOR
Intervention: Root canal treatment
Number of subjects: 54
Study: 25534724

Group type: EXPERIMENTAL
Intervention: 200 mg of LFF571 four times daily for 10 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: 125 mg of vancomycin four times daily for 10 days
Number of subjects: 0
Study: 23962593

Group type: EXPERIMENTAL
Intervention: Closed reduction between days 1-5 after injury
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Closed reduction between days 6-10 after injury
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Overall closed reduction treatment
Number of subjects: 24
Study: 21258836

Group type: EXPERIMENTAL
Intervention: Goshajinkigan (GJG) 7.5 g/day during mFOLFOX6 therapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no GJG)
Number of subjects: 45
Study: 19038483

Group type: EXPERIMENTAL
Intervention: TTM-based self-help intervention
Number of subjects: 2471

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 2471
Study: 17766506

Group type: EXPERIMENTAL
Intervention: Healthy Steps
Number of subjects: 5565
Study: 14985685

Group type: EXPERIMENTAL
Intervention: DHA group (n=20) took active foods containing fish oil (3.6 g DHA/week) for 2 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (n=20) took indistinguishable control foods without fish oil
Number of subjects: 40
Study: 11767271

Group type: EXPERIMENTAL
Intervention: BASICS (Brief Alcohol Screening and Intervention for College Students)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Educational intervention
Number of subjects: 99

Group type: COMPARATOR
Intervention: Assessment-only control group
Number of subjects: 99
Study: 9599737

Group type: COMPARATOR
Intervention: Enuretic group (treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group A (low UOP, large NUV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Before treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: After treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group D (normal UOP, small NUV)
Number of subjects: 0
Study: 7977541

Group type: EXPERIMENTAL
Intervention: Dilapan osmotic dilator
Number of subjects: 1001

Group type: COMPARATOR
Intervention: Laminaria japonicum
Number of subjects: 1001
Study: 2732164

Group type: COMPARATOR
Intervention: 12% O2 for 20 min
Number of subjects: 9

Group type: COMPARATOR
Intervention: 10% O2 for 20 min
Number of subjects: 9

Group type: COMPARATOR
Intervention: 8% O2 for 10 min
Number of subjects: 9
Study: 143889

Group type: EXPERIMENTAL
Intervention: Induced abortion with concurrent tubal ligation (Group 1)
Number of subjects: 2421

Group type: COMPARATOR
Intervention: Induced abortion only (Group 2)
Number of subjects: 2421

Group type: COMPARATOR
Intervention: Interval culdoscopic ligation
Number of subjects: 2421
Study: 30817436

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 28903775

Group type: EXPERIMENTAL
Intervention: Saxagliptin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5-hydroxy saxagliptin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Animal studies
Number of subjects: 0
Study: 26002049

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg/day
Number of subjects: 102
Study: 23780782

Group type: EXPERIMENTAL
Intervention: Sleep (12 hours with sleep)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wakefulness (12 hours without sleep)
Number of subjects: 60
Study: 21373802

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TES)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TES) in children with normal upper GI motility (NUGM)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TES) in children with upper gastrointestinal dysmotility (UGD)
Number of subjects: 46
Study: 19631046

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral weight control program (12-week, 12 sessions of 1 hour each)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral weight control program
Number of subjects: 216
Study: 17091118

Group type: EXPERIMENTAL
Intervention: Home-based STI self-collection and testing
Number of subjects: 818

Group type: COMPARATOR
Intervention: Clinic appointment
Number of subjects: 818
Study: 15056136

Group type: EXPERIMENTAL
Intervention: 18-mm spot size
Number of subjects: 0

Group type: COMPARATOR
Intervention: 12-mm spot size
Number of subjects: 0
Study: 11313839

Group type: EXPERIMENTAL
Intervention: clomipramine
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: sertraline
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: paroxetine
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: sildenafil
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: pause-squeeze technique
Number of subjects: 31
Study: 9389847

Group type: EXPERIMENTAL
Intervention: Crystalloid priming with Ringer's lactate
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Human albumin priming solution
Number of subjects: 26

Group type: COMPARATOR
Intervention: Coronary artery bypass surgery (control group)
Number of subjects: 26
Study: 7911562

Group type: EXPERIMENTAL
Intervention: 100 Hz tetanic stimulation
Number of subjects: 25

Group type: COMPARATOR
Intervention: 50 Hz tetanic stimulation
Number of subjects: 25
Study: 3316303

Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide (5 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Combined treatment (Bendroflumethiazide + Nifedipine)
Number of subjects: 17
Study: 31810865

Group type: EXPERIMENTAL
Intervention: Biomarker-guided recommendation on antibiotics (n=104)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Routine use of antibiotics (n=106)
Number of subjects: 210
Study: 29702672

Group type: EXPERIMENTAL
Intervention: AIDSVAX®B/E
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ALVAC-HIV/AIDSVAX®B/E
Number of subjects: 0

Group type: COMPARATOR
Intervention: ALVAC-HIV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AIDSVAX®B/E and ALVAC-HIV/AIDSVAX®B/E
Number of subjects: 0
Study: 27367045

Group type: EXPERIMENTAL
Intervention: High-intensity neuromuscular training (NMT) program for 12 weeks
Number of subjects: 725
Study: 25676082

Group type: EXPERIMENTAL
Intervention: Supporting Father Involvement intervention
Number of subjects: 0
Study: 23203337

Group type: EXPERIMENTAL
Intervention: BioCleanse-sterilized allografts
Number of subjects: 67

Group type: COMPARATOR
Intervention: aseptic BTB allografts
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 67
Study: 20511693

Group type: EXPERIMENTAL
Intervention: Early weight bearing after surgical repair of ATR
Number of subjects: 73
Study: 18588355

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg once daily
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: NCB-02 (curcumin 150 mg twice daily)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 16630994

Group type: EXPERIMENTAL
Intervention: FENO plus EZE
Number of subjects: 576
Study: 14622893

Group type: EXPERIMENTAL
Intervention: Home-based intervention consisting of 10 weekly lessons focusing on child health and home safety.
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Home-based intervention
Number of subjects: 63
Study: 10773185

Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8846863

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg twice daily)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Radiotherapy (40 Gy)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg twice daily) after crossover
Number of subjects: 143

Group type: COMPARATOR
Intervention: Radiotherapy (40 Gy) after crossover
Number of subjects: 143
Study: 1444318

Group type: EXPERIMENTAL
Intervention: MAB-T88 (1 mg/kg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: MAB-T88 (4 mg/kg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: MAB-T88 (8 mg/kg)
Number of subjects: 9
Study: 4036787

Group type: EXPERIMENTAL
Intervention: iopamidol
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: urografin
Number of subjects: 42
Study: 30919154

Group type: EXPERIMENTAL
Intervention: Structured exercise program of aerobic and active resistance exercises for 11 weeks
Number of subjects: 148

Group type: COMPARATOR
Intervention: Standard physical activity recommendations
Number of subjects: 148
Study: 29901441

Group type: EXPERIMENTAL
Intervention: Firehawk (bioabsorbable polymer sirolimus‐eluting stent)
Number of subjects: 1656

Group type: COMPARATOR
Intervention: XIENCE (durable polymer drug‐eluting stent)
Number of subjects: 1656

Group type: EXPERIMENTAL
Intervention: Firehawk
Number of subjects: 1656

Group type: COMPARATOR
Intervention: XIENCE
Number of subjects: 1656
Study: 27082108

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg daily for a maximum of 12 weeks
Number of subjects: 249

Group type: COMPARATOR
Intervention: Traditional analgesia alone (Control Group)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg daily
Number of subjects: 249
Study: 24158940

Group type: EXPERIMENTAL
Intervention: DA-6034 10, 20, 50, 100 or 200 mg single dose
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: DA-6034 40, 100 or 200 mg/day multiple doses for 7 days
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo (not specified dosage)
Number of subjects: 67
Study: 23046749

Group type: EXPERIMENTAL
Intervention: Sativex®
Number of subjects: 666

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 666
Study: 20035530

Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux‐en‐Y gastric bypass (LRYGB)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Laparoscopic biliopancreatic diversion with duodenal switch (LDS)
Number of subjects: 60
Study: 17564669

Group type: EXPERIMENTAL
Intervention: Mechanical vibration (60 Hz) for 30 min using ATL massage devices
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (non-vibratory) devices
Number of subjects: 0
Study: 16601828

Group type: EXPERIMENTAL
Intervention: 270 microg/kg rFVIIa
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 90 microg/kg rFVIIa (3 doses at 3-hour intervals)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Both regimens
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: rFVIIa
Number of subjects: 42
Study: 14585671

Group type: EXPERIMENTAL
Intervention: HA/Vi vaccine
Number of subjects: 116

Group type: COMPARATOR
Intervention: Avaxim vaccine
Number of subjects: 116
Study: 10881952

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 49
Study: 8624269

Group type: EXPERIMENTAL
Intervention: Pamidronate 120 mg infusion
Number of subjects: 20
Study: 1294606

Group type: EXPERIMENTAL
Intervention: PHZ102 (Inpharzam SA, Cadempino, Switzerland) containing EGF
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo eyedrops
Number of subjects: 0
Study: 6387529

Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg single dose and 30 mg/day for 2 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg single dose and 240 mg/day for 2 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 30168266

Group type: EXPERIMENTAL
Intervention: Elective inguinal hernia repair (open or laparoscopic)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (patients undergoing surgery for other diseases)
Number of subjects: 103
Study: 26907090

Group type: EXPERIMENTAL
Intervention: Breast milk containing FUT2-dependent oligosaccharides
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control (placebo group)
Number of subjects: 266
Study: 26273143

Group type: EXPERIMENTAL
Intervention: Captopril pretreatment for 3 days (Cap3d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single dose captopril (Cap1hr) before surgery with Iso (Cap1hr+Iso)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Captopril (Cap) 24 hours before MI/R in rabbits
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iso (isoflurane) in rabbits
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of captopril and Iso (Iso+Cap) in rabbits
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated control (Control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham operation (Sham)
Number of subjects: 0

Group type: COMPARATOR
Intervention: MI/R (I/R)
Number of subjects: 0
Study: 24151017

Group type: EXPERIMENTAL
Intervention: Sevelamer carbonate (starting dose 800 mg three times daily)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Sevelamer carbonate
Number of subjects: 205
Study: 22552763

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate 220 mg once daily
Number of subjects: 8135

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate 150 mg once daily
Number of subjects: 8135

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 8135
Study: 19939335

Group type: EXPERIMENTAL
Intervention: Antimicrobial silver dressings
Number of subjects: 304

Group type: COMPARATOR
Intervention: Non-adherent control dressings
Number of subjects: 304
Study: 17495474

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 15037936

Group type: EXPERIMENTAL
Intervention: Micronized purified flavonoid fraction with routine antibiotic and anti‐inflammatory treatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine antibiotic and anti‐inflammatory treatment alone (control)
Number of subjects: 50
Study: 11779396

Group type: COMPARATOR
Intervention: Cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine (CAIV-T)
Number of subjects: 0
Study: 9090267

Group type: EXPERIMENTAL
Intervention: Mental arithmetic task with threat of shock
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mental arithmetic task without threat of shock
Number of subjects: 40
Study: 7942878

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA) with morphine sulfate 1 mg or meperidine hydrochloride 10 mg, six-minute lockout period
Number of subjects: 36

Group type: COMPARATOR
Intervention: Intramuscular (i.m.) analgesic therapy with meperidine hydrochloride 75-100 mg every three to four hours as needed
Number of subjects: 36